• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

EMHSX:US

12.99 USD 0.28 2.11%

As of 19:59:59 ET on 07/31/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (EMHSX)

Year To Date: +11.22% 3-Month: +7.27% 3-Year: +19.94% 52-Week Range: 9.98 - 13.38
1-Month: -0.99% 1-Year: +28.70% 5-Year: +17.01% Beta vs SPX: 0.93

Mutual Fund Chart for EMHSX

No chart data available.
  • EMHSX:US 12.99
  • 1M
  • 1Y
Interactive EMHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for EMHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 09-23-1996 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for EMHSX

NAV (on 2014-07-31) 12.99
Assets (M) (on 2014-06-30) 1,412.49
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for EMHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-17) 0.16
Dividend Yield (ttm) 10.23

Fees & Expenses for EMHSX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 0.91
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.14

Top Fund Holdings for EMHSX

Filing Date: 05/31/2014
Name Position Value % of Total
Roche Holding AG 293,000 86,362,391 6.348%
Bristol-Myers Squibb Co 1,230,000 61,180,200 4.497%
HCA Holdings Inc 1,130,000 59,878,700 4.401%
AbbVie Inc 1,084,000 58,893,720 4.329%
Gilead Sciences Inc 675,000 54,816,750 4.029%
Merck & Co Inc 932,000 53,925,520 3.964%
Mylan Inc/PA 1,070,000 53,328,800 3.920%
Illumina Inc 326,400 51,652,800 3.797%
Allergan Inc/United States 289,200 48,429,432 3.560%
Biogen Idec Inc 149,600 47,777,752 3.512%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil